Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

WIL Research Company Selects Q Exactive Mass Spectrometer

Published: Thursday, June 28, 2012
Last Updated: Wednesday, June 27, 2012
Bookmark and Share
HR/AM capability to expand the company’s regulated bioanalysis, drug discovery and metabolism/structural identification services.

Thermo Fisher Scientific Inc. has announced that WIL Research Company, Inc. has selected Thermo Scientific Q Exactive hybrid quadrupole-Orbitrap mass spectrometer systems to expand its capabilities for regulated bioanalysis, drug discovery, metabolism and structural identification services.

The systems were validated for GLP compliance using Thermo Fisher Scientific Validation Support Services.

These services dramatically reduce the overall validation burden by providing test scripts specifically customized for WIL Research’s standard operating procedures and system requirements.

“The Q Exactive™ system offers greater flexibility and simpler operation than our triple quadrupole mass spectrometer systems, and will be extremely effective in addressing our most challenging analytical projects,” said Dr. Terry Johnson, Director of Metabolism, WIL Research.

Dr. Johnson continued, “The system’s versatility, ruggedness and sensitivity make it very well suited to qualitative drug metabolism, as well as quantitative studies.”

The Q Exactive system’s unique HR/AM capability will expand the analytical capabilities that WIL Research can provide to its customers.

The Q Exactive system is the first commercially available mass spectrometer to bring together quadrupole precursor selection and high-resolution, accurate-mass Orbitrap™ mass analysis to deliver high-confidence quantitative and qualitative (quan/qual) workflows.

With innovative HR/AM Quanfirmation capability, the Q Exactive mass spectrometer makes it possible to identify, quantify and confirm more trace-level drugs, metabolites, peptides and proteins in complex mixtures.

Unlike other HR/AM technologies, high-confidence results are obtained without sacrificing quantitative LLOQ’s, reproducibility or mass resolution.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Scientific at ASMS 2013
Learn how scientists and researchers are transforming science by applying innovative solutions to a wide range of qualitative and quantitative applications.
Monday, May 13, 2013
Thermo Fisher Scientific to Acquire Life Technologies Corporation
The definitive agreement will see Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share or approximately $13.6 billion.
Monday, April 15, 2013
Thermo Fisher Scientific Reports Q3 Revenue and EPS Results
Revenue increased 5% to a record $3.09 billion for the third quarter with adjusted operating income rising 5% to $576 million.
Wednesday, October 24, 2012
Thermo Fisher Scientific Forms Technology Alliance Partnership with Princeton Scientists
The collaboration will focus on advancing LC/MS techniques in life science research.
Tuesday, August 14, 2012
Thermo Fisher Scientific Equips the Scottish Metabolomics Facility with Cutting-Edge Technology to Advance the Field of Metabolomics
Thermo Fisher Scientific Inc., today announced it is providing the Scottish Metabolomics Facility (ScotMet) with cutting-edge technology to advance the field of metabolomics.
Thursday, March 18, 2010
Scientific News
Could the Food we Eat Affect Our Genes?
Almost all of our genes may be influenced by the food we eat, according to new research.
Charting Kidney Cancer Metabolism
Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.
Cytoskeleton Crew
Findings confirm sugar's role in helping cancers survive by changing cellular architecture.
Microbiome May Hold the Key to Fighting Obesity
In a unique study of free-ranging brown bears, Swedish researchers were able to show that the bears’ dietary variation goes hand-in-hand with dramatic changes in the animal’s gut microbiota.
Cancer Cells Kill Off Healthy Neighbours
Cancer cells create space to grow by killing off surrounding healthy cells, according to UK researchers working with fruit flies.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Toxicity Testing With Cultured Liver Cells
Microreactor replaces animal testing.
Proteins Seek, Attack, Destroy Tumor Cells in Bloodstream
Using white blood cells to ferry potent cancer-killing proteins through the bloodstream virtually eliminates metastatic prostate cancer in mice, Cornell researchers have confirmed.
Why Do Some Infections Persist?
In preparing for the possibility of an antibiotic onslaught, some bacterial cultures adopt an all-for-one/one-for-all strategy that would make a socialist proud, University of Vermont researchers have found.
Flipping Molecular 'Switch' May Reduce Nicotine's Effects in the Brain
Scientists at The Scripps Research Institute (TSRI) have discovered that a lipid (fat molecule) in brain cells may act as a “switch” to increase or decrease the motivation to consume nicotine.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!